Panigrahi, Pinaki
Parida, Sailajanandan
Nanda, Nimai C.
Satpathy, Radhanath
Pradhan, Lingaraj
Chandel, Dinesh S.
Baccaglini, Lorena
Mohapatra, Arjit
Mohapatra, Subhranshu S.
Misra, Pravas R.
Chaudhry, Rama
Chen, Hegang H.
Johnson, Judith A.
Morris, J. Glenn
Paneth, Nigel
Gewolb, Ira H.
Article History
Received: 14 November 2016
Accepted: 7 July 2017
First Online: 16 August 2017
Change Date: 30 November 2017
Change Type: Correction
Change Details: Please see accompanying Corrigendum (
Change Details: https://doi.org/10.1038/nature25006
Change Details: ). In this Article, the statement ‘There were 88 culture-positive and 94 culture-negative cases’ has been corrected to ‘Apart from 88 cases of suspect sepsis that included both culture-negative and culture-positive infants, there were an additional 94 culture-negative cases’.
Competing interests
: Following institutional procedures for federally funded grants, a new invention disclosure on the use of a combination of <i>L. plantarum</i> and fructooligosaccharides against infection and inflammation was made to the UNMC office of technology transfer (UNeMed). UNeMed, upon its decision not to pursue the invention, has released the rights to the inventor (P.P.). A PCT patent application has been filed (pending examination) and assigned to the Asian Institute of Public Health. None of the authors, including P.P., has any financial or management interest with any commercial entity.